Not the way TGA works and should be fully segregated and not considered IMO. Paying $93k is possibly simplest lowest cost way to move on if initial representations to have it reversed or changed came to nothing. With Covid and general TGA warning issued to all pharma the window to avoid advertising penalties and cop a warning may have been very small ( or non existant) for a listed company .. Next stages of TGA enforcement get more serious IMO and best avoided along with long drawn out legal cases that end up argueing fine legal point at a great $ cost and long period. Once things cross the line and become a formal fine unless it is clear that it is specifically injust or in error which would have to be proved by SPL it stands .
SPL Price at posting:
$1.26 Sentiment: None Disclosure: Not Held
